Best Brachytherapy Doctors Worldwide — TOP 42

Dr. Solak specializes in brachytherapy at Hisar Hospital Intercontinental, with training from Hacettepe University Cancer Institute and MD Anderson Cancer Center.

• Completed fellowship at Hacettepe University Cancer Institute
• Trained at The University of Texas MD Anderson Cancer Center
• Specializes in breast, testicular, ovarian, lung, and head-neck cancers
• Residency at Istanbul Sisli Etfal Teaching and Research Hospital

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in brachytherapy for complex cases.

• Over 41 years of experience of experience in orthopedic oncology
• Trained in brachytherapy at NY Hospital and Institut Gustave Roussy
• Member of ESMO Sarcoma Faculty and ASCO
• Published extensively on sarcoma and bone malignancies

Dr. Shira Felder leads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior radiation oncologist specializing in gynecologic and urologic cancers. She trained at the Princess Margaret Cancer Centre in Toronto. Dr. Felder focuses on delivering targeted radiation while preserving her patients' quality of life.

• Uses precision techniques including VMAT, IMRT, SBRT, and brachytherapy.
• Treats cervical, uterine, ovarian, and prostate cancers.
• Maintains membership in the European Society for Radiotherapy & Oncology.
• Works at Sheba Medical Center, ranked 7th globally by Newsweek.
• Conducts research on brachytherapy safety and cervical cancer survival.

Professor Miralbell is a world-renowned expert in prostate cancer treatment with radiotherapy, collaborating with CERN on advanced radiation techniques.

• Head of Radiation Oncology at Centro Médico Teknon since 1999
• Specializes in focused radiosurgery including Gammaknife and Cyberknife
• Trained at Harvard Cyclotron Laboratory and Royal Marsden Hospital
• Recipient of the Varian Award for Radiation Oncology
• Published over 100 scientific papers on radiotherapy advancements

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Board-certified in Radiotherapy and Radiation Oncology, Dr. Zamboglou leads prostate cancer research and specializes in precise brachytherapy techniques.

• Head of Interventional Radiation Oncology at Medical Center University of Freiburg
• Recipient of the prestigious Herman-Holthusen Award
• Invited member of ESTRO-ACROP guideline committee for prostate cancer
• Published multiple studies on advanced radiation techniques

Completed fellowship at the renowned Anderson Cancer Center, specializing in brachytherapy for gynecologic cancers. Coordinates groundbreaking MRI-guided ultrasound tumor treatment studies.

• Residency in general oncology and radiotherapy at Sheba Hospital
• Specializes in oncogynecological brachytherapy and SBRT techniques
• Active researcher studying molecular response to radiation therapy
• Member of ASTRO and ISCORT professional societies
• Recognized as Sheba Hospital's best employee in 2007

Phd Viola Fox specializes in comprehensive tumor treatments, including brachytherapy, at Medical Center in Solingen.

• Board-certified haematologist, oncologist, and immunologist since 2011
• Chief Physician at a certified interdisciplinary cancer center
• Active in molecular biology research for innovative cancer therapies
• Member of German and American oncology societies

Associate Professor Dr. Yusuf Acikgoz brings international oncology expertise from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in Medical Oncology with a focus on brachytherapy
• Participated in Phase III clinical trials like CheckMate-649 and Fortitude-101
• Trained at prestigious institutions including Ankara Numune Training and Research Hospital
• Member of American Society of Clinical Oncology (ASCO)
• Certified in Good Clinical Practice and Human Subjects Protection

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

36 years of experience specializing in oncology and radiotherapy – Dr. Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center.

• Board-certified in both oncology and radiotherapy
• Head of Gastrointestinal Cancer Center at Hadassah
• Member of Israel Society of Clinical Oncology
• Fluent in English and Hebrew for international patients

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Mohamed Mahmoud Abdelhakim is a Professor of Radiation Oncology at Cairo University’s National Cancer Institute. He serves as the Head of Radiation Oncology at Shefa al Orman Hospital. Dr. Abdelhakim treats complex cancers, including breast, soft tissue sarcoma, and gynecologic tumors. He is a member of ESTRO and ESMO.

• Performs image-guided brachytherapy and stereotactic radiotherapy.
• Uses IMRT, VMAT, SRS, and SBRT for precise tumor targeting.
• Provides total body and total skin irradiation for bone marrow transplants.
• Practices at ESMO-accredited Shefa al Orman Hospital in Luxor.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Svetlana Zalmanova specializes in brachytherapy at Assuta Medical Center, bringing focused expertise to targeted radiation treatments.

• Radiotherapy specialist with dedicated experience in brachytherapy
• Practices at Assuta Medical Center, a leading facility for advanced treatments
• Skilled in precise tumor targeting while minimizing impact on healthy tissue

Board-certified surgical oncologist specializing in brachytherapy at Galenia Hospital. Member of the Mexican Society of Oncology.

• 6 years of experience of experience in surgical oncology
• Board-certified by Conacem until 2030
• University teacher at Universidad Anahuac since 2020
• Trained at Centro Medico Nacional 20 de Noviembre